Silencing of FAM111B inhibited proliferation, migration and invasion of hepatoma cells through activating p53 pathway.

[1]  E. Zhang,et al.  MNX1-AS1 promotes phase separation of IGF2BP1 to drive c-Myc-mediated cell cycle progression and proliferation in lung cancer. , 2022, Cancer research.

[2]  C. Che,et al.  Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway , 2022, Cellular & Molecular Biology Letters.

[3]  M. Caraglia,et al.  p53: From Fundamental Biology to Clinical Applications in Cancer , 2022, Biology.

[4]  Xiaokun Zhao,et al.  Azelnidipine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by targeting MEK1/2 , 2022, Molecular therapy oncolytics.

[5]  W. Cai,et al.  DNMT3B-mediated FAM111B methylation promotes papillary thyroid tumor glycolysis, growth and metastasis , 2022, International journal of biological sciences.

[6]  K. Engeland.  Cell cycle regulation: p53-p21-RB signaling , 2022, Cell Death & Differentiation.

[7]  S. Kantevari,et al.  Autophagic and apoptotic cell death induced by the quinoline derivative 2‐(6‐methoxynaphthalen‐2‐yl)quinolin‐4‐amine in pancreatic cancer cells is via ER stress and inhibition of Akt/mTOR signaling pathway , 2022, Drug development research.

[8]  Xinkui Liu,et al.  A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation , 2021, Chinese Medicine.

[9]  A. Brazma,et al.  The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences , 2021, Nucleic Acids Res..

[10]  D. Boll,et al.  Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization , 2021, Cell Reports Medicine.

[11]  Xuejun Jiang,et al.  YY1-Induced Transcriptional Activation of FAM111B Contributes to the Malignancy of Breast Cancer. , 2021, Clinical breast cancer.

[12]  Yue Zhao,et al.  USP14 maintains HIF1-α stabilization via its deubiquitination activity in hepatocellular carcinoma , 2021, Cell Death & Disease.

[13]  Yo-Han Han,et al.  Inhibitory Effect of Gallotannin on Lung Metastasis of Metastatic Colorectal Cancer Cells by Inducing Apoptosis, Cell Cycle Arrest and Autophagy. , 2021, The American journal of Chinese medicine.

[14]  E. Prochownik,et al.  FBXL6 degrades phosphorylated p53 to promote tumor growth , 2021, Cell Death & Differentiation.

[15]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[16]  Li Jin,et al.  Global trend of aetiology-based primary liver cancer incidence from 1990 to 2030: a modelling study. , 2020, International journal of epidemiology.

[17]  Gongye Zhang,et al.  Knocking down USP39 Inhibits the Growth and Metastasis of Non-Small-Cell Lung Cancer Cells through Activating the p53 Pathway , 2020, International journal of molecular sciences.

[18]  Chiang-Ching Huang,et al.  Multiplex Digital PCR to Detect Amplifications of Specific Androgen Receptor Loci in Cell-Free DNA for Prognosis of Metastatic Castration-Resistant Prostate Cancer , 2020, Cancers.

[19]  E. Morii,et al.  FAM111B enhances proliferation of KRAS‐driven lung adenocarcinoma by degrading p16 , 2020, Cancer science.

[20]  Bin-hui Ren,et al.  FAM111B, a direct target of p53, promotes the malignant process of lung adenocarcinoma , 2019, OncoTargets and therapy.

[21]  T. Taddei,et al.  Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies , 2019, Digestive Diseases and Sciences.

[22]  B. Zhou,et al.  lncRNA HOXB-AS3 promotes hepatoma by inhibiting p53 expression. , 2018, European Review for Medical and Pharmacological Sciences.

[23]  Hong Lin,et al.  The UbL-UBA Ubiquilin4 protein functions as a tumor suppressor in gastric cancer by p53-dependent and p53-independent regulation of p21 , 2018, Cell Death & Differentiation.

[24]  T. Srdić-Rajić,et al.  Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies , 2017, Journal of hepatocellular carcinoma.

[25]  C. Pérez-Plasencia,et al.  Gene signature based on degradome-related genes can predict distal metastasis in cervical cancer patients , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[26]  H. Aburatani,et al.  SCFFbxo22-KDM4A targets methylated p53 for degradation and regulates senescence , 2016, Nature Communications.

[27]  A. Munnich,et al.  Expanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations , 2015, Orphanet Journal of Rare Diseases.

[28]  R. Redon,et al.  Mutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis. , 2013, American journal of human genetics.

[29]  Gary K. Chen,et al.  Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese , 2012, Nature Genetics.

[30]  Feng Wang,et al.  Substrate Phosphorylation and Feedback Regulation in JFK-promoted p53 Destabilization* , 2010, The Journal of Biological Chemistry.

[31]  R. DePinho,et al.  Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression. , 2006, Cancer research.

[32]  H. Hsu,et al.  Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma. , 1998, Journal of hepatology.

[33]  A. Levine,et al.  The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.

[34]  S. Deb,et al.  ChIP sequencing to identify p53 targets. , 2013, Methods in molecular biology.